Trial phases (Phase 1, 2, 3)
The stages a new treatment must pass through before it can be approved for routine use.
What it is
In cancer research, a new treatment must go through several stages, or phases, before it can be approved for use in hospitals. These phases are like checkpoints that ensure the treatment is safe and effective. A phase is a step in the process where researchers test the treatment on a small group of people to see how it works.
How it works
During each phase, researchers carefully monitor the participants to see how the treatment affects them. In Phase 1, the focus is on safety and finding the right dose. In Phase 2, researchers look at how well the treatment works and if it has any side effects. Phase 3 is where the treatment is compared to the standard treatment to see which one is more effective.
Why it matters
Understanding trial phases is important for patients and carers because it helps them understand what to expect from a new treatment. It also gives them a sense of how far along the treatment is in the research process. By knowing the phase, patients can make informed decisions about whether to participate in a clinical trial.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.